Table 3.
SGLT-2i prescriptions in type 2 diabetes according to BMI category in individuals with or without heart failure
| BMI categorya | SGLT-2i with heart failure (N = 1157) |
SGLT-2i without heart failure (N = 25,543) |
|---|---|---|
| Underweight | 0 (0.0) | 18 (0.1) |
| Normal weight | 54 (4.7) | 1396 (5.5) |
| Overweight | 229 (19.8) | 6149 (24.1) |
| Obese | 855 (73.9) | 17,595 (68.9) |
| Missing | 19 (1.6) | 385 (1.5) |
Data are presented as n(%)
BMI body mass index, SGLT-2i sodium–glucose co‐transporter‐2 inhibitor
aBMI categories closest to first SGLT-2- prescription: underweight, < 18.5 kg/m2; normal, 18.5 − 24.9 kg/m2; overweight, 25.0 − 29.9 kg/m2; obese, > 30 kg/m2